Yoni Lubeck

946 total citations
7 papers, 165 citations indexed

About

Yoni Lubeck is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoni Lubeck has authored 7 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoni Lubeck's work include Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Ferroptosis and cancer prognosis (2 papers). Yoni Lubeck is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Ferroptosis and cancer prognosis (2 papers). Yoni Lubeck collaborates with scholars based in Netherlands, Germany and Switzerland. Yoni Lubeck's co-authors include Erik Hooijberg, Joyce Sanders, Dennis Peters, Judy R. van Beijnum, Wilbert Zwart, Ingrid Hofland, Andries M. Bergman, Annegien Broeks, Henk G. van der Poel and Anniek Zaalberg and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Yoni Lubeck

7 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoni Lubeck Netherlands	6	90	79	37	33	23	7	165
Wenxiao Dai China	6	126 1.4×	115 1.5×	37 1.0×	20 0.6×	30 1.3×	7	270
Alessio Cirillo Italy	8	164 1.8×	64 0.8×	49 1.3×	27 0.8×	24 1.0×	22	218
Jorge Dunstan Peru	7	132 1.5×	44 0.6×	16 0.4×	10 0.3×	33 1.4×	17	163
Gabriella Lionetto Italy	7	95 1.1×	49 0.6×	27 0.7×	35 1.1×	29 1.3×	24	142
Rachel Coleby United Kingdom	6	29 0.3×	45 0.6×	16 0.4×	18 0.5×	9 0.4×	9	120
Л. Д. Жуйкова Russia	8	53 0.6×	41 0.5×	22 0.6×	8 0.2×	17 0.7×	33	154
Mandeep Hundal United States	3	32 0.4×	96 1.2×	33 0.9×	24 0.7×	21 0.9×	6	185
Moeko Hino Japan	6	63 0.7×	44 0.6×	13 0.4×	11 0.3×	12 0.5×	15	138
Renaud Maire Switzerland	5	136 1.5×	38 0.5×	25 0.7×	18 0.5×	20 0.9×	7	205
Elettra Unti Italy	9	43 0.5×	49 0.6×	41 1.1×	70 2.1×	12 0.5×	14	170

Countries citing papers authored by Yoni Lubeck

Since Specialization

Citations

This map shows the geographic impact of Yoni Lubeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoni Lubeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoni Lubeck more than expected).

Fields of papers citing papers by Yoni Lubeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoni Lubeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoni Lubeck. The network helps show where Yoni Lubeck may publish in the future.

Co-authorship network of co-authors of Yoni Lubeck

This figure shows the co-authorship network connecting the top 25 collaborators of Yoni Lubeck. A scholar is included among the top collaborators of Yoni Lubeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoni Lubeck. Yoni Lubeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gil-Jimenez, Alberto, Nick van Dijk, Joris L. Vos, et al.. (2024). Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature Communications. 15(1). 2538–2538. 10 indexed citations

2.

Disselhorst, Maria, Yoni Lubeck, Vincent van der Noort, et al.. (2022). Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?. Lung Cancer. 173. 49–52. 1 indexed citations

3.

Dijk, Nick van, Alberto Gil-Jimenez, Karīna Siliņa, et al.. (2021). The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer. Frontiers in Immunology. 12. 793964–793964. 28 indexed citations

4.

Cimino‐Mathews, Ashley, Yoni Lubeck, Mark Opdam, et al.. (2020). Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. European Journal of Cancer. 127. 240–250. 18 indexed citations

5.

Cioni, B., Anniek Zaalberg, Judy R. van Beijnum, et al.. (2020). Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion. Nature Communications. 11(1). 4498–4498. 84 indexed citations

6.

Dijk, Nick van, Karīna Siliņa, Kees Hendricksen, et al.. (2020). Biomarker analysis and updated clinical follow-up of preoperative ipilimumab (ipi) plus nivolumab (nivo) in stage III urothelial cancer (NABUCCO).. Journal of Clinical Oncology. 38(15_suppl). 5020–5020. 5 indexed citations

7.

Heijden, Michiel S. van der, Nick van Dijk, Laura A. Smit, et al.. (2019). Pre-operative ipilimumab and nivolumab in locoregionally advanced, stage III, urothelial cancer (NABUCCO). Annals of Oncology. 30. v358–v358. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact